Rehabilitation for non-motor symptoms for patients with Parkinson's disease from an α-synuclein perspective: a narrative review.

Exploration of neuroprotective therapy Pub Date : 2023-01-01 Epub Date: 2023-08-27 DOI:10.37349/ent.2023.00049
Zhaoyang Liu, Jessica Lemus, Irina V Smirnova, Wen Liu
{"title":"Rehabilitation for non-motor symptoms for patients with Parkinson's disease from an α-synuclein perspective: a narrative review.","authors":"Zhaoyang Liu,&nbsp;Jessica Lemus,&nbsp;Irina V Smirnova,&nbsp;Wen Liu","doi":"10.37349/ent.2023.00049","DOIUrl":null,"url":null,"abstract":"<p><p>Parkinson's disease (PD) is a common neurodegenerative disorder affecting aged population around the world. PD is characterized by neuronal Lewy bodies present in the substantia nigra of the midbrain and the loss of dopaminergic neurons with various motor and non-motor symptoms associated with the disease. The protein α-synuclein has been extensively studied for its contribution to PD pathology, as α-synuclein aggregates form the major component of Lewy bodies, a hallmark of PD. In this narrative review, the authors first focus on a brief explanation of α-synuclein aggregation and circumstances under which aggregation can occur, then present a hypothesis for PD pathogenesis in the peripheral nervous system (PNS) and how PD can spread to the central nervous system from the PNS via the transport of α-synuclein aggregates. This article presents arguments both for and against this hypothesis. It also presents various non-pharmacological rehabilitation approaches and management techniques for both motor and non-motor symptoms of PD and the related pathology. This review seeks to examine a possible hypothesis of PD pathogenesis and points to a new research direction focus on rehabilitation therapy for patients with PD. As various non-motor symptoms of PD appear to occur earlier than motor symptoms, more focus on the treatment of non-motor symptoms as well as a better understanding of the biochemical mechanisms behind those non-motor symptoms may lead to better long-term outcomes for patients with PD.</p>","PeriodicalId":73000,"journal":{"name":"Exploration of neuroprotective therapy","volume":" ","pages":"235-257"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621781/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploration of neuroprotective therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37349/ent.2023.00049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/27 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder affecting aged population around the world. PD is characterized by neuronal Lewy bodies present in the substantia nigra of the midbrain and the loss of dopaminergic neurons with various motor and non-motor symptoms associated with the disease. The protein α-synuclein has been extensively studied for its contribution to PD pathology, as α-synuclein aggregates form the major component of Lewy bodies, a hallmark of PD. In this narrative review, the authors first focus on a brief explanation of α-synuclein aggregation and circumstances under which aggregation can occur, then present a hypothesis for PD pathogenesis in the peripheral nervous system (PNS) and how PD can spread to the central nervous system from the PNS via the transport of α-synuclein aggregates. This article presents arguments both for and against this hypothesis. It also presents various non-pharmacological rehabilitation approaches and management techniques for both motor and non-motor symptoms of PD and the related pathology. This review seeks to examine a possible hypothesis of PD pathogenesis and points to a new research direction focus on rehabilitation therapy for patients with PD. As various non-motor symptoms of PD appear to occur earlier than motor symptoms, more focus on the treatment of non-motor symptoms as well as a better understanding of the biochemical mechanisms behind those non-motor symptoms may lead to better long-term outcomes for patients with PD.

α-突触核蛋白视角下帕金森病患者非运动症状的康复:叙述性综述
帕金森病(PD)是一种常见的神经退行性疾病,影响着世界各地的老年人。帕金森病的特征是中脑黑质中存在神经元路易体,多巴胺能神经元丧失,并伴有与该疾病相关的各种运动和非运动症状。蛋白质α-突触核蛋白因其对帕金森病病理学的贡献而被广泛研究,因为α-突触蛋白聚集体是帕金森病的标志性路易体的主要组成部分。在这篇叙述性综述中,作者首先简要解释了α-突触核心蛋白聚集体以及可能发生聚集体的情况,然后提出了外周神经系统(PNS)中PD发病机制的假设,以及PD如何通过α-突触核蛋白聚集体的转运从PNS传播到中枢神经系统。这篇文章提出了支持和反对这一假设的论据。它还介绍了各种非药物康复方法和管理技术,包括帕金森病的运动和非运动症状以及相关病理学。这篇综述试图检验帕金森病发病机制的一个可能假设,并为帕金森病患者的康复治疗指明了一个新的研究方向。由于帕金森病的各种非运动症状似乎比运动症状更早发生,更多地关注非运动症状的治疗,以及更好地了解这些非运动症状背后的生化机制,可能会为PD患者带来更好的长期结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书